Tymon Pol

Uppsala Science Park
Uppsala, C 75237, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Type 2 diabetes and chronic kidney disease combinations in heart failure across the ejection fraction spectrum: clinical associations, medication use, and cause-specific outcomes: a contemporary, real-world analysis of the Swedish Heart Failure Registry.

Type 2 diabetes and chronic kidney disease combinations in heart failure across the ejection fraction spectrum: clinical associations, medication use, and cause-specific outcomes: a contemporary, real-world analysis of the Swedish Heart Failure Registry.

Journal: European journal of heart failure

Published: May 20, 2026

Plasma Biomarkers Associated With Heart Failure Hospitalization Among Patients With Atrial Fibrillation and Subtypes of Heart Failure.

Plasma Biomarkers Associated With Heart Failure Hospitalization Among Patients With Atrial Fibrillation and Subtypes of Heart Failure.

Journal: Journal of the American Heart Association

Published: January 14, 2026

Cardiomyopathies: Nationwide Trends in Prevalence, Incidence, and Mortality (2004-2023).

Cardiomyopathies: Nationwide Trends in Prevalence, Incidence, and Mortality (2004-2023).

Journal: Journal of the American College of Cardiology

Published: October 09, 2025

The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design.

The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design.

Journal: European journal of heart failure

Published: August 07, 2024

Heart failure registries - Future directions.

Heart failure registries - Future directions.

Journal: Journal of cardiology

Published: June 27, 2023

Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.

Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 27, 2021

Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.

Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.

Journal: Cardiovascular research

Published: February 12, 2021

Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation.

Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation.

Journal: Journal of the American Heart Association

Published: December 09, 2020

Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas.

Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas.

Journal: Open heart

Published: October 15, 2020

Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial.

Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial.

Journal: Journal of the American Heart Association

Published: February 09, 2018

Showing 1-10 of 10

Last Updated: 09/26/2026